This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hausman, S Z
Right arrow Articles by Manclark, C R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausman, S Z
Right arrow Articles by Manclark, C R

 Previous Article  |  Next Article 

Infect Immun. 1989 June; 57(6): 1760-1764

Immune response to dimeric subunits of the pertussis toxin B oligomer.

S Z Hausman, D L Burns, V C Sickler and C R Manclark

Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892.

ABSTRACT

Immunization of mice with the dimeric subunits of pertussis toxin (S2-S4 and S3-S4) induced an antibody response detectable by enzyme-linked immunosorbent assay and immunoblot techniques. These antibodies were able to neutralize the ability of pertussis toxin to alter the morphology of Chinese hamster ovary cells. Mice immunized with the dimers were also protected against the leukocytosis-promoting effects of toxin. Based on these data, the dimers of pertussis toxin may be considered for further study as potential vaccine candidates.


Infect Immun. 1989 June; 57(6): 1760-1764